cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism. Takimoto E, Champion HC, Belardi D, Moslehi J, Mongillo M, Mergia E, Montrose DC, Isoda T, Aufiero K, Zaccolo M, Dostmann WR, Smith CJ, Kass DA (2005) Circ Res 96: 100-9 Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice. Kang L, Ayala JE, Lee-Young RS, Zhang Z, James FD, Neufer PD, Pozzi A, Zutter MM, Wasserman DH (2011) Diabetes 60: 416-26 Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH (2007) Diabetes 56: 1025-33 Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Gamboa A, Shibao C, Diedrich A, Paranjape SY, Farley G, Christman B, Raj SR, Robertson D, Biaggioni I (2008) Hypertension 51: 1531-6 The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men. Dishy V, Sofowora G, Harris PA, Kandcer M, Zhan F, Wood AJ, Stein CM (2001) Clin Pharmacol Ther 70: 270-9 A Common CD36 Variant Influences Endothelial Function and Response to Treatment with Phosphodiesterase 5 Inhibition. Shibao CA, Celedonio JE, Ramirez CE, Love-Gregory L, Arnold AC, Choi L, Okamoto LE, Gamboa A, Biaggioni I, Abumrad NN, Abumrad NA (2016) J Clin Endocrinol Metab 101: 2751-8 Treatment with Sildenafil Improves Insulin Sensitivity in Prediabetes: A Randomized, Controlled Trial. Ramirez CE, Nian H, Yu C, Gamboa JL, Luther JM, Brown NJ, Shibao CA (2015) J Clin Endocrinol Metab 100: 4533-40 Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension. Johnson RF, Loyd JE, Mullican AL, Fink CA, Robbins IM (2007) J Heart Lung Transplant 26: 363-9 Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD (2004) Mol Pharmacol 65: 1462-74 Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation. Hemnes AR, Robbins IM (2009) Liver Transpl 15: 15-9 Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers. Dishy V, Harris PA, Pierce R, Prasad HC, Sofowora G, Bonar HL, Wood AJ, Stein CM (2004) Br J Clin Pharmacol 57: 209-12 Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil. Zhu CB, Hewlett WA, Francis SH, Corbin JD, Blakely RD (2004) Eur J Pharmacol 504: 1-6 Sildenafil-induced vasorelaxation is associated with increases in the phosphorylation of the heat shock-related protein 20 (HSP20). Tessier DJ, Komalavilas P, McLemore E, Thresher J, Brophy CM (2004) J Surg Res 118: 21-5 Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension. Robbins IM, Hemnes AR, Gibbs JS, Christman BW, Howard L, Meehan S, Cabrita I, Gonzalez R, Oyler T, Zhao L, Du RH, Mendes LA, Wilkins MR (2011) Exp Lung Res 37: 26-34 Acute effects of sildenafil in patients with primary pulmonary hypertension receiving epoprostenol. Kuhn KP, Wickersham NE, Robbins IM, Byrne DW (2004) Exp Lung Res 30: 135-45
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.